Original Research
Published on 18 Sep 2019
Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01070
- 5,274 views
- 22 citations
Type at least 3 characters
1,081 articles
Articles
Correction
Published on 18 Sep 2019
Corrigendum: Dioscin Inhibits HSC-T6 Cell Migration via Adjusting SDC-4 Expression: Insights From iTRAQ-Based Quantitative Proteomics
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01036
- 1,644 views
- 2 citations
Original Research
Published on 13 Sep 2019
Protective Effects of Dioscin Against Doxorubicin-Induced Hepatotoxicity Via Regulation of Sirt1/FOXO1/NF-Îşb Signal
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.01030
- 12,812 views
- 113 citations
Original Research
Published on 12 Sep 2019
Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00966
- 3,015 views
- 1 citation
Original Research
Published on 16 Aug 2019
Baicalein Mitigates Radiation-Induced Enteritis by Improving Endothelial Dysfunction
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00892
- 5,170 views
- 38 citations
Original Research
Published on 15 Aug 2019
Astragaloside IV Protects Ethanol-Induced Gastric Mucosal Injury by Preventing Mitochondrial Oxidative Stress and the Activation of Mitochondrial Pathway Apoptosis in Rats
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00894
- 3,822 views
- 28 citations
Original Research
Published on 02 Aug 2019
Small Intestine Protection of Mica Against Non-Steroidal Anti-Inflammatory Drugs-Injury Through ERK1/2 Signal Pathway in Rats
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00871
- 2,405 views
- 2 citations
Review
Published on 29 Jul 2019
Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00853
- 10,831 views
- 90 citations
Review
Published on 26 Jul 2019
Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00837
- 9,327 views
- 66 citations
Review
Published on 23 Jul 2019
Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00730
- 13,724 views
- 61 citations
Original Research
Published on 19 Jul 2019
Comparison of Different Liver Test Thresholds for Drug-Induced Liver Injury: Updated RUCAM versus Other Methods
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00816
- 4,006 views
- 17 citations
Original Research
Published on 04 Jul 2019
Hepatopoietin Cn (HPPCn) Generates Protective Effects on Acute Liver Injury
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00646
- 2,789 views
- 7 citations
Original Research
Published on 02 Jul 2019
RETRACTED: MiR-519b-3p Inhibits the Proliferation and Invasion in Colorectal Cancer via Modulating the uMtCK/Wnt Signaling Pathway
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00741
- 2,306 views
- 23 citations
Brief Research Report
Published on 26 Jun 2019
The Impact of Mevastatin on HCV Replication and Autophagy of Non-Transformed HCV Replicon Hepatocytes Is Influenced by the Extracellular Lipid Uptake
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00718
- 2,684 views
- 7 citations
Review
Published on 18 Jun 2019
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00671
- 10,382 views
- 64 citations
Original Research
Published on 17 Jun 2019
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00691
- 5,513 views
- 20 citations